Navigation Links
The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
Date:6/19/2008

The award recognizes outstanding journalism demonstrating the essential role of humane animal research in medical discoveries and scientific breakthroughs.

WASHINGTON, June 19 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) today announces the winners of the 7th Annual Michael E. DeBakey Journalism Awards. The awards, named in honor of FBR's Chairman and 2008 Congressional Gold Medal recipient Dr. Michael E. DeBakey, recognize outstanding journalism that discusses the essential role of humane animal research in medical discoveries and scientific breakthroughs.

"All advances in medicine have an underlying basis in medical research," said Dr. DeBakey. "It is absolutely critical to perform medical research if we are to advance medical science. All animal research -- that I know of, in any institution that I'm familiar with -- is done with great care; and is done with special concern for the ethical treatment of the animal."

The 2008 winners are as follows: Gautam Naik of The Wall Street Journal, Marie McCullough of The Philadelphia Inquirer, Academy Awards nominated directors Steven Ascher and Jeanne Jordan, Richard Ingham and Pia Ohlin of Agence France-Presse (AFP), Howard Bell of Minnesota Medicine Magazine, Tom Walsh of The Ellsworth American, and Terri Peterson Smith of Science and Technology Magazine. The judging panel was composed of both members of the media and the scientific community.

"We applaud a well-balanced and accurate discussion of animal research," said FBR president Frankie Trull. "The DeBakey awards are a unique opportunity for scientists and the media to converge in celebration of strides in science and medicine."

A ceremony to honor the winners will be held on Monday, June 23rd, 2008. For more information about the award winners and their work, please visit FBR's website: http://www.fbresearch.org.

Established in 1981, FBR
'/>"/>

SOURCE Foundation for Biomedical Research
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
2. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
3. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
4. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
5. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
6. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
7. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
10. Gates Foundation Seeks Proposals for Innovative Global Health Research
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , NEW YORK, Nov. 30 Report...port is available in its catalogue: ,, Surgica.../www.reportlinker.com/p0164299/Surgical-Incision-C...ion closures market holds enormous significance, d...rformed each year. Surgical disciplines such as ca...
(Date:11/30/2009)..., KING OF PRUSSIA, Pa., Nov. 30 ... completion of a Phase I study of CPSI-2364, its o...uction of TNF-alpha and other pro-inflammatory cyt...se escalation study in healthy volunteers confirm ...sting. ,, All 30 enrolled subjects completed ...
(Date:11/30/2009)..., CHICAGO, Nov. 30 MedPro Imagi...asound solutions, will showcase leading ultrasound...iq I and Siemens X300 Premium Edition during the c...rth America (RSNA) conference, being held in Chica... MedPro Imaging markets ultrasound products and se...
Breaking Medicine Technology:Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Relators Attorneys Comment On AtriCure DOJ Proposed Settlement 5996 1Relators Attorneys Comment On AtriCure DOJ Proposed Settlement 5996 2USGS science picks 10641 1USGS science picks 10641 2USGS science picks 10641 3USGS science picks 10641 4USGS science picks 10641 5USGS science picks 10641 6USGS science picks 10641 7TV bombards children with commercials for high fat and high sugar foods 10639 1TV bombards children with commercials for high fat and high sugar foods 10639 2TV bombards children with commercials for high fat and high sugar foods 10639 3
...YORK, May 16 Pulmo BioTech Inc. (OTC,Bulletin Boa...ogy and,purpose of its Phase I Human Trials with i...diagnosis of Pulmonary Embolism and Pulmonary,Hype...lmo BioTech subsidiary,PulmoScience Inc., and the ... PulmoBind for Molecular Imaging of the Pulmonary ...
...GEWATER, N.J., May 16 Data from three studies,eva...emoglobin (Hb) levels,and the rate of blood transf...ions on reimbursement for erythropoiesis-stimulati...n,s blood supply, will be presented at the,America...ng later this,month. The meeting will take place i...
Other Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6
(Date:11/30/2009)... , SILVER SPRING, Md., Nov. 30 /PRNewswir... consumers a bronzed body year-round, but the ultr...rious health risks. ,, (Logo: http://www.news...though some people think that a tan gives them a ,...says Sharon Miller, M.S.E.E., a Food and Drug Admi...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Physicians a...ported today on results of a study demonstrating t... angiography (cCTA) by Rcadia,s COR Analyzer Syste...rtery stenosis in hospital emergency department (E...utomated system to enhance the use of cCTA has pot...
(Date:11/30/2009)...niversity of Navarra Hospital has launched a serie...cy of an immunotherapy treatment. This approach in...oduced from healthy and tumour cells from the pati...tomas, one of the most aggressive and frequent mal... participating patients combined with the standard...
(Date:11/30/2009)... Peter J. Rappa, MD, explores th...dy in his new book "Healing Heart to Soul: On...ife" (Brown Books 2009). , ...periencing and refusing to let go of negative emot... can weigh heavy on our shoulders. Oftentimes, thi...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Gene ...unities ,, http://www.reportlinker.com/p01642...ortunities.html ,, Gene therapy promises to b... Although no significant achievements for curing d...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5
...place the tissue it sloughs off is controlled by a...l School published in the May 4 issue of Cell, ho...eneration process not only for skin, but for many ...ose relative to the well-known tumor-suppressing p...
...vent mice from developing a brain disease similar ...l be presented at the American Academy of Neurolo...5, 2007. Prion diseases, which include scrapie, ma...s of other animals contaminated with prions. The d...
...Administration (FDA) today issued the "Critical Pa...ying many of the unanswered scientific questions ... commonly used drugs. The report is part of F...path from discovery, or proof of concept, to a mar...
...seem to have made headway in the development of an... vulnerability of patients to develop complicatio... difficulties. A conjoined effort between Bri...ect such tendencies. Researchers have pro...
...jailed for killing a disabled Sydney cabbie last J... was beaten up by the two fourteen year olds. Th...ghter and were jailed for six years. The taxi... were overcome with emotion after Supreme Cou...
...est bread companies is not happy with the proposal...ic acid. They are petitioning the state and federa...objective of such a proposal is to enhance the fol...reenshields from Goodman Fielder about what he thi...
Other Medicine News:Health News:Master Regulatory Gene of Epithelial Stem Cells Identified 2Health News:Vaccine Prevents Prion Disease in Mice 2Health News:New Critical Path Report Highlights Research Needed to Foster Generic Drug Development 2
...e OrthoPilot, physicians now have a tool for the p...,The only platform you need for all orthopedic in...tem requiring little space. Continuous software up... OrthoPilot a strong and trustworthy partner. At t...
Optifield EP-900 Series
AP-125 Automatic Perimeter
...EXCLUDER AAA Endoprosthesis is an innovative devic...tion for patients with abdominal aortic aneurysms ...ated graft with an outer self-expanding Nitinol su... and material durability. The function of the endo...
Medicine Products: